Tranexamic acid use in severely injured patients, is it always appropriate?
| Autor: | J.A. Varela, L. Gonzalez-Zarco, P. Duque, S. Gago, R. Martínez |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Trauma patient
business.industry Fibrinolysis Hemorrhage 030208 emergency & critical care medicine General Medicine Blood Coagulation Disorders 030204 cardiovascular system & hematology medicine.disease Hyperfibrinolysis Antifibrinolytic Agents Pulmonary embolism 03 medical and health sciences 0302 clinical medicine Tranexamic Acid Blunt trauma Acido tranexamico Anesthesia medicine Coagulopathy Humans business Tranexamic acid Major bleeding medicine.drug |
| Zdroj: | Revista Española de Anestesiología y Reanimación (English Edition). 68:301-303 |
| ISSN: | 2341-1929 |
| Popis: | Recently, it has been suggested that tranexamic acid should be administered only in those patients with hyperfibrinolysis determined using viscoelastic assays, as severely injured patients may present with fibrinolytic shutdown. However the last European guidelines on management of major bleeding and coagulopathy following trauma endorse the use of tranexamic acid to the trauma patient who is bleeding or at risk of significant hemorrhage as soon as possible without waiting for viscoelastic results. We present a severely blunt trauma patient treated with on-scene administration of tranexamic acid that developed immediate pulmonary embolism. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect